Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Plan ahead with key data on upcoming stock reports - all in 1 place
See Calendar
Close

Dynavax Technologies Corporation (DYF1)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.87 +0.20    +2.03%
07:08:41 - Delayed Data. Currency in EUR
Type:  Equity
Market:  Germany
ISIN:  US2681582019 
S/N:  A12EV9
  • Volume: 153
  • Bid/Ask: 9.75 / 9.90
  • Day's Range: 9.87 - 9.87
Dynavax 9.87 +0.20 +2.03%

Dynavax Technologies Corp Company Profile

 
Get an in-depth profile of Dynavax Technologies Corporation, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

405

Equity Type

ORD

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Contact Information

Address 2100 Powell Street Suite 720
EmeryVille, 94608
United States
Phone 510 848 5100
Fax 510 848 1327

Top Executives

Name Age Since Title
Scott D. Myers 57 2021 Independent Chairman of the Board
Ryan Spencer 46 2019 CEO & Director
Daniel L. Kisner 78 2010 Independent Director
Emilio A. Emini 72 2025 Director
Robert L. Coffman 78 2000 Member of Scientific Advisory Board
Stanley A. Plotkin 92 2005 Member of Scientific Advisory Board
Francis R. Cano 80 2009 Independent Director
E. John Wherry - 2018 Member of Scientific Advisory Board
Miriam Merad - 2018 Member of Scientific Advisory Board
Laura Q. M. Chow - 2018 Member of Scientific Advisory Board
Andrew Mark Pardoll - 2018 Member of Scientific Advisory Board
Brent MacGregor 61 2020 Independent Director
Elaine D. Sun 53 2021 Independent Director
Peter R. Paradiso 74 2020 Chairman of the Scientific Advisory Board & Independent Director
Rino Rappuoli 73 2023 Member of Scientific Advisory Board
Kathryn M. Edwards - 2023 Member of Scientific Advisory Board
Lauren P. Silvernail 67 2025 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DVAX Comments

Write your thoughts about Dynavax Technologies Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email